Table 1.
Activation type/function | Source | Substances produced | Reference |
---|---|---|---|
M1 (classical activation): pro-inflammatory and pro-killing | LPS, IFN-γ | Cytokines: IL-1β, IL-6, IL-12, IL-17, IL-18, IL-23, TNF-α | Mahad and Ransohoff, 2003; Kawanokuchi et al., 2006 Kawanokuchi et al., 2008; Loane and Byrnes, 2010; Benarroch, 2013; Chhor et al., 2013; Franco and Fernandez-Suarez, 2015; Nakagawa and Chiba, 2015 |
Markers: CD86, MHC-II | |||
Chemokines: CCL2 | |||
Metabolic enzyme/redox molecules: iNOS, COX-2, reactive oxygen species and reactive nitrogen species prostaglandin E2 | |||
M2a (alternative activation): tissue repair and phagocytosis | IL-4, IL-13 | Cytokines: IL-10 | Mahad and Ransohoff, 2003; Loane and Byrnes, 2010, Benarroch, 2013; Chhor et al., 2013; Franco and Fernandez-Suarez, 2015; Nakagawa and Chiba, 2015 |
Markers: CD206, SR-A1, SR-B1, Arg1, Ym1, Fizz1 | |||
Others: extracellular matrix proteins, PPAR | |||
M2b (alternative activation): recruitment of regulatory T cells | Fcγ receptors, TLRs and immune complexes (IgG) | Cytokines: IL-1β, IL-6, IL-10, TNF-α | |
Markers: CD86, MHC-II | |||
Others: SOCS3, COX-2, Sphk | |||
M2c (alternative activation): anti-inflammatory and healing | IL-10, TGF-β and glucocorticoids | Cytokines: IL-10, TGF-β | |
Markers: CD163 | |||
Arg1, arginase 1; CCL, chemokine (C-C motif) ligand; CD, cluster of differentiation; COX-2, cyclooxygenase-2; Fizz1, found in inflammatory zone; IFN-γ, interferon-γ; IL, interleukin; iNOS, inducible nitric oxide synthase; MHC-II, major histocompatibility complex II; SOCS3, suppressor of cytokine signaling-3; Sphk, sphingosine kinase; SR-A1, scavenger receptor class A1; SR-B1, scavenger receptor class B1; TGF, transforming growth factor; TNF-α, tumor necrosis factor-α; Ym1, chitinase-like protein.